Submitted:
19 March 2024
Posted:
20 March 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract. 2014; 103(3):341–63. [CrossRef]
- HAPO Study Cooperative Research Group; Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358(19):1991–2002. [CrossRef]
- Rasmussen L, Poulsen CW, Kampmann U, Smedegaard SB, Ovesen PG, Fuglsang J. Diet and healthy lifestyle in the management of gestational diabetes mellitus. Nutrients. 2020; 12(10):1–24. [CrossRef]
- Moorhead SA, Hazlett DE, Harrison L, Carroll JK, Irwin A, Hoving C. A new dimension of health care: systematic review of the uses, benefits, and limitations of social media for health communication. J Med Internet Res. 2013; 15(4):e85. [CrossRef]
- Wang Y, McKee M, Torbica A, Stuckler D. Systematic Literature Review on the Spread of Health-related Misinformation on Social Media. Soc Sci Med. 2019; 240:112552. [CrossRef]
- Lindsay KL, Brennan L, Kennelly MA, Curran S, Coffey M, Smith TP, Foley ME, Hatunic M, McAuliffe FM. Maternal metabolic response to dietary treatment for impaired glucose tolerance and gestational diabetes mellitus. Ir J Med Sci. 2018; 187(3):701-8. [CrossRef]
- American Diabetes Association, Professional Practice Committee. 15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022; 45:S232–43. [CrossRef]
- Park AJ, Maruthur MK, Swerlick RA. Information technologies in health care delivery and policy: giant steps and missteps. Semin Cutan Med Surg. 2019; 38(1):E25–30. [CrossRef]
- Gabarron E, Arsand E, Wynn R. Social media use in interventions for diabetes: Rapid evidence-based review. J Med Internet Res. 2018; 20(8):e10303. [CrossRef]
- Al Omar M, Hasan S, Palaian S, Mahameed S. The impact of a self-management educational program coordinated through WhatsApp on diabetes control. Pharm Pract (Granada). 2020; 18(2):1–9. [CrossRef]
- Metzger BE. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33(3):676–82. [CrossRef]
- Sweeting A, Wong J, Murphy HR, Ross GP. A Clinical Update on Gestational Diabetes Mellitus. Endocr Rev. 2022; 43(5):763-93. [CrossRef]
- Casey PH, Goolsby SLP, Lensing SY, Perloff BP, Bogle ML. The use of telephone interview methodology to obtain 24-hour dietary recalls. J Am Diet Assoc. 1999; 99(11):1406–11. [CrossRef]
- Guendelman S, Krueger GN, Cruz GI, Trepman PC, Suharwardy SH. Use of Telehealth During the COVID-19 Pandemic Among Practicing Maternal-Fetal Medicine Clinicians. Telemedicine and e-Health. 2023; 29(5):696–707. [CrossRef]
- Ghosh A, Arora B, Gupta R, Anoop S, Misra A. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diabetes Metab Syndr. 2020; 14(5):917-920. [CrossRef]
- Pietrobelli A, Pecoraro L, Ferruzzi A, Heo M, Faith M, Zoller T, Antoniazzi F, Piacentini G, Fearnbach SN, Heymsfield SB. Effects of COVID-19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study. Obesity (Silver Spring). 2020; 28(8):1382–5. [CrossRef]
- Nardo B, Lugaresi M, Doni M, Vulcano I, Piccione D, Paglione D, Stabile G. WhatsApp video call communication between oncological patients and their families during COVID-19 outbreak. Minerva Surg. 2021; 76(2):146-155. [CrossRef]
- Enyama D, Balti EV, Simeni Njonnou SR, Ngongang Ouankou C, Kemta Lekpa F, Noukeu Njinkui D, Fouogue JT, Mayouego Kouam J, Njateng GSS, Kenfack B, et al. Use of WhatsApp®, for distance teaching during COVID-19 pandemic: Experience and perception from a sub-Saharan African setting. BMC Med Educ. 2021; 21(1):517. [CrossRef]
- Ngo J, Engelen A, Molag M, Roesle J, García-Segovia P, Serra-Majem L. A review of the use of information and communication technologies for dietary assessment. Br J Nutr. 2009; 101 Suppl 2:S102-12. [CrossRef]
- Jaichuen N, Vandevijvere S, Kelly B, Vongmongkol V, Phulkerd S, Tangcharoensathien V. Unhealthy food and non-alcoholic beverage advertising on children's, youth and family free-to-air and digital television programmes in Thailand. BMC Public Health. 2018; 18(1):737. [CrossRef]
- Hung M, Lipsky MS, Phuatrakoon TN, Nguyen M, Licari FW, Unni EJ. Teledentistry Implementation During the COVID-19 Pandemic: Scoping Review. Interact J Med Res. 2022; 11(2):e39955. [CrossRef]
- Kanchan S, Gaidhane A. Social Media Role and Its Impact on Public Health: A Narrative Review. Cureus. 2023; 15(1):e33737. [CrossRef]
- Konttila J, Siira H, Kyngäs H, Lahtinen M, Elo S, Kääriäinen M, Kaakinen P, Oikarinen A, Yamakawa M, Fukui S, et al. Healthcare professionals' competence in digitalisation: A systematic review. J Clin Nurs. 2019; 28(5-6):745-761. [CrossRef]
- Smith M, Mitchell AS, Townsend ML, Herbert JS. The relationship between digital media use during pregnancy, maternal psychological wellbeing, and maternal-fetal attachment. PLoS One. 2020; 15(12):e0243898. [CrossRef]
- Tian Y, Zhang S, Huang F, Ma L. Comparing the Efficacies of Telemedicine and Standard Prenatal Care on Blood Glucose Control in Women With Gestational Diabetes Mellitus: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2021; 9(5): e22881. [CrossRef]
- Kennelly MA, Ainscough K, Lindsay K, Gibney E, Mc Carthy M, McAuliffe FM. Pregnancy, exercise and nutrition research study with smart phone app support (Pears): Study protocol of a randomized controlled trial. Contemp Clin Trials. 2016; 46:92–9. [CrossRef]


| Variables | Groups | Total | p-value | |
|---|---|---|---|---|
| CG (n=34) | IG (n=47) | |||
| Age | 35.5 (26-46; SD 4.8) | 33.4 (18-43; SD 6.1) | 0.081 | |
| Number of pregnancies | 3.4 (1-8; SD 1.6) | 2.9 (1-6; SD 1.4) | 0.162 | |
| BMI at inclusion | 31.1 (21.2-43.4; SD 7.9) | 28.8 (20.6-44.9; SD 5) | 0.073 | |
| Ethnicity | n (%) | n (%) | n (%) | 0.32 |
| Black | 7 (20.6%) | 15 (31.9%) | 22 (27.2%) | |
| Latin | 17 (50%) | 15 (31.9%) | 32 (39.5%) | |
| White | 10 (29.4%) | 16 (34.0%) | 26 (32.1%) | |
| Other | 0 | 1 (2.1%) | 1 (1.2%) | |
| Marital status | n (%) | n (%) | n (%) | 0.465 |
| Married | 17 (50.0%) | 28 (59.6%) | 45 (55.6%) | |
| Living with partner | 7 (20.6%) | 11 (23.6%) | 18 (22.2%) | |
| Single | 9 (26.5%) | 8 (17.0%) | 17 (21.0%) | |
| Others | 1 (2.9%) | 0 | 1 (1.2%) | |
| Total | Group | ||||||
|---|---|---|---|---|---|---|---|
| Glucose blood levels | Control | Intervention | p-value ¥ | ||||
| n | % | n | % | n | % | ||
| First week | |||||||
| Adequate | 14 | 17.3 | 6 | 17.6 | 8 | 17 | 0.857 |
| Non adequate | 17 | 21 | 6 | 17.6 | 11 | 23.4 | |
| Non executed | 50 | 61.7 | 22 | 64.7 | 28 | 59.6 | |
| Total | 81 | 100 | 34 | 47 | |||
| Second week | |||||||
| Adequate | 38 | 47.6 | 12 | 36.4 | 26 | 55.3 | 0.262 |
| Non adequate | 21 | 26.2 | 11 | 33.3 | 10 | 21.3 | |
| Non executed | 21 | 26.2 | 10 | 30.3 | 11 | 23.4 | |
| Total | 80 | 100 | 33 | 47 | |||
| Third week | |||||||
| Adequate | 42 | 53.9 | 11 | 35.5 | 31 | 66 | 0.027 |
| Non adequate | 21 | 26.9 | 12 | 38.7 | 9 | 19.1 | |
| Non executed | 15 | 19.2 | 8 | 25.8 | 7 | 14.9 | |
| Total | 78 | 100 | 31 | 47 | |||
| Fourth week | |||||||
| Adequate | 45 | 64.3 | 10 | 35.7 | 35 | 83.3 | <0.001 |
| Non adequate | 15 | 21.4 | 10 | 35.7 | 5 | 11.9 | |
| Non executed | 10 | 14.3 | 8 | 28.6 | 2 | 4.8 | |
| Total | 70 | 100 | 28 | 42 | |||
| Fifth week | |||||||
| Adequate | 47 | 74.6 | 13 | 56.5 | 34 | 85 | 0.04 |
| Non adequate | 12 | 19.1 | 8 | 30.4 | 5 | 12.5 | |
| Non executed | 4 | 6.3 | 3 | 13 | 1 | 2.5 | |
| Total | 63 | 100 | 23 | 40 | |||
| Sixth week | |||||||
| Adequate | 42 | 75 | 10 | 52.6 | 32 | 86.5 | 0.011 |
| Non adequate | 12 | 21.4 | 8 | 41.1 | 4 | 10.8 | |
| Non executed | 2 | 3.6 | 1 | 5.3 | 1 | 2.7 | |
| Total | 56 | 100 | 19 | 37 | |||
| Seventh week | |||||||
| Adequate | 29 | 74.4 | 4 | 40 | 25 | 86.2 | 0.009 |
| Non adequate | 8 | 20.5 | 5 | 50 | 3 | 10.3 | |
| Non executed | 2 | 5.1 | 1 | 10 | 1 | 3.4 | |
| Total | 39 | 100 | 10 | 29 | |||
| Eighth week | |||||||
| Adequate | 14 | 58.4 | 3 | 4.9 | 11 | 64.7 | 0.566 |
| Non adequate | 5 | 20.8 | 2 | 28.6 | 3 | 17.6 | |
| Non executed | 5 | 20.8 | 2 | 28.6 | 3 | 17.6 | |
| Total | 24 | 100 | |||||
| Variables | Group | p-value & | ||||
| Control | Intervention | |||||
| Median (IIC) | n | Median (IIC) | n | |||
| Calories (cal) | ||||||
| T0 | 1278.6 (1059.3-1486.7) | 34 | 1318.3 (1186.5-1617.6) | 47 | 0.193 | |
| T1 | 1186.5 (1085-1316.8) | 33 | 1322.1 (1149.4-1484) | 47 | 0.051 | |
| T2 | 1216.3 (1124.1-1380) | 31 | 1270.5 (1113.8-1451.9) | 46 | 0.329 | |
| T3 | 1328.5 (1099-1443.6) | 29 | 1255.7 (1157.2-1536.2) | 43 | 0.617 | |
| T4 | 1238.3 (1072.4-1358.6) | 18 | 1325.6 (1171.1-1548.3) | 35 | 0.126 | |
| T5 | 1247.9 (1087.4-1444.6) | 10 | 1240.6 (1088.6-1529) | 25 | 0.733 | |
| TF | 1241.4 (1059.2-1425.1) | 33 | 1325.1 (1160-1588.3) | 47 | 0.178 | |
| Proteins (g) | ||||||
| T0 | 97.4 (68.1-112.4) | 34 | 97.6 (72.4-116.8) | 47 | 0.466 | |
| T1 | 99.4 (54-112.2) | 33 | 104.1 (75.9-116.6) | 47 | 0.104 | |
| T2 | 98.2 (74.5-104.7) | 31 | 90.1 (72.8-111.1) | 46 | 0.787 | |
| T3 | 98.3 (68.7-110.8) | 29 | 104 (76.5-115.8) | 43 | 0.23 | |
| T4 | 90.6 (69.9-102.6) | 18 | 104.7 (84-119) | 35 | 0.049 | |
| T5 | 90.1 (55-108.8) | 10 | 93.9 (63-113.6) | 25 | 0.691 | |
| TF | 71.2 (53.2-108.8) | 33 | 102 (83.1-116.1) | 47 | 0.021 | |
| Carbohydrates (g) | ||||||
| T0 | 142.4 (110.8-158.6) | 34 | 156.3 (129-186) | 47 | 0.088 | |
| T1 | 119.8 (105.9-145.6) | 33 | 144.1 (121.1-164.8) | 47 | 0.039 | |
| T2 | 127.1 (110-149) | 31 | 133.5 (117.4-155.3) | 46 | 0.262 | |
| T3 | 124.6 (105.5-144.4) | 29 | 139.6 (117.7-172.8) | 43 | 0.097 | |
| T4 | 124.3 (99.5-142.9) | 18 | 137.8 (113-162.3) | 35 | 0.036 | |
| T5 | 128.1 (110.9-138.9) | 10 | 132.1 (106.6-167.1) | 25 | 0.205 | |
| TF | 124.6 (107-146.8) | 33 | 137.8 (112-173.2) | 47 | 0.205 | |
| Lipids (g) | ||||||
| T0 | 32.7 (28.3-47.9) | 34 | 36.5 (28.2-45.8) | 47 | 0.612 | |
| T1 | 41.4 (29.9-48.3) | 33 | 39.8 (29.7-48.2) | 47 | 0.949 | |
| T2 | 41.5 (33.4-50.8) | 31 | 36.8 (29-55.8) | 46 | 0.633 | |
| T3 | 41.9 (33.3-52.1) | 29 | 41.6 (29.2-49.5) | 43 | 0.701 | |
| T4 | 43.3 (31.1-56.7) | 18 | 104 (84-119) | 35 | <0.001 | |
| T5 | 45 (36.3-54.3) | 10 | 93.9 (63-113.6) | 25 | <0.001 | |
| TF | 43.4 (35.3-55.2) | 33 | 86 (54.9-103.9) | 47 | <0.001 | |
| Fibers (g) | ||||||
| T0 | 21.6 (17.1-27.4) | 34 | 27 (19.5-31.1) | 47 | 0.04 | |
| T1 | 20.9 (18.6-27) | 33 | 25.8 (22.7-29.4) | 47 | 0.044 | |
| T2 | 21.5 (19.8-25.9) | 31 | 25 (18.9-28.7) | 46 | 0.303 | |
| T3 | 19.3 (14.5-24) | 29 | 23.7 (15.5-28) | 43 | 0.05 | |
| T4 | 20.5 (17.1-22.1) | 18 | 22.8 (17.6-28.2) | 35 | 0.054 | |
| T5 | 19.5 (14.3-22.9) | 10 | 24.7 (18.2-26.6) | 25 | 0.371 | |
| TF | 18.9 (14.5-22.4) | 33 | 23.7 (17.4-27.5) | 47 | 0.02 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).